Real-world data/evidence case studies
Learn more about our expertise
Learn more about our work from our library of real-world evidence/data case studies and explore our in-depth scientific expertise across disciplines.
Understanding the breast cancer patient journey
A biopharma company sought a clear, data‑driven view of the HER2⁺ mBC patient journey to improve forecasting, brand strategy, and medical engagement, lacking a unified perspective.
Transitioning from a Phase 3 study to an EAP
This case study highlights the strategic execution of an Expanded Access Program (EAP) across multiple global regions, Europe, Asia-Pacific, and Latin America, following a Phase 3 clinical study.
Rapid deployment of a compassionate use program
During the peak of the COVID-19 pandemic, a global compassionate use program (CUP) was urgently needed to provide compassionate use of a promising treatment. The program required rapid deployment across multiple regions to support hospitalized patients.
Consolidation of multiple protocols into a single LTE oncology study
To ensure continuity of care for participants in the maintenance phase of multiple parent studies in oncology managed by ICON and third-party vendors, a consolidated long-term extension (LTE) protocol was required.
Integration of multiple oncology studies into a single OLE study
An oncology study involving 53 parent protocols - each with distinct timelines, sites, databases, and reporting requirements - needed to be integrated into a single open-label extension (OLE) study.
From early engagement to award
An established customer sought to streamline patient follow-up across multiple clinical protocols, each involving different sponsors and assets, to support ongoing treatment and safety data collection.
Impact of point of care marketing in hospital settings
A major Point of Care (PoC) Publisher partnered with Symphony Health to evaluate an unbranded cardiovascular treatment campaign targeting hospital-affiliated physicians nationwide. The campaign used printed condition guides to engage HCPs and patients during key decision-making moments.
Achieving highly accurate social media measurement
Symphony Health partnered with a social media company to develop a privacy-compliant ad measurement solution for a pharma client. Using machine learning, they maintained 90% accuracy while meeting stricter privacy standards—offering a scalable model for regulated environments.
Quantifying the impact of SDOH
Understanding Social Determinants of Health (SDOH) is key to addressing disparities and improving outcomes in Type 2 Diabetes. While factors like diet and access to care are known, quantifying their impact on diagnosis, treatment initiation, and adherence remains an emerging focus.
Using RWE to differentiate TYK2 inhibitors in a crowded psoriasis market
A pharma company partnered with Symphony Health to guide the launch of a TYK2 inhibitor for psoriasis. They explored market potential, free drug programs, treatment patterns, and prescribing behavior—especially among NPs and PAs—to shape positioning in a competitive landscape.
Disparities in access to branded migraine therapies
CGRP inhibitors have expanded migraine treatment, but payer barriers often limit access, especially for vulnerable groups. A patient advocacy client worked with Symphony Health to explore disparities in access and their impact on outcomes like ER visits and hospitalizations.
Leveraging Real-World Data and machine learning
Early cancer detection is vital, yet many cases—especially lung cancer—are diagnosed late, limiting treatment options. Life sciences organizations now use real-world data and machine learning to identify subtle, pre-diagnostic signals in patient journeys, enabling earlier intervention and improved outcomes.